Middletown, DE -- (SBWIRE) -- 09/23/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Raptor Pharmaceutical Corp. (NASDAQ:RPTP), Ares Capital Corporation (NASDAQ:ARCC), Orexigen Therapeutics, Inc. (NASDAQ:OREX), Neurocrine Biosciences, Inc. (NASDAQ:NBIX).
Raptor Pharmaceutical Corp. (NASDAQ:RPTP) opened its last trade at the price of $14.51. Its closing price was $14.36 after losing -0.97% for the day. The company traded with the total volume of 3.22 million shares, while its average trading volume remained 969,998.00 shares. The beta of this stock stands at 1.09. Raptor Pharmaceuticals Corp. operates as a development stage biotechnology company in the United States. It engages in the research, manufacture, and commercialization of medicines to treat nephropathic cystinosis, non-alcoholic steatohepatitis (NASH), Huntington's disease (HD), and aldehyde dehydrogenase deficiency (ALDH2).
Has RPTP Found The Bottom and Ready To Move Up? Find Out Here
Ares Capital Corporation (NASDAQ:ARCC) percentage change plunged -1.02% to close at $17.45 with the total traded volume of 2.25 million shares, along with average volume of 1.35 million. The 52 week range of the stock remained $16.03 - $18.67, while its day lowest price was $17.29. The share price hit the day highest price of $17.75. Ares Capital Corporation (Ares Capital) is a specialty finance company, which is a closed-end, non-diversified management investment company. The Company’s wholly owned subsidiaries and vehicles managed or sub-managed by its wholly owned portfolio company, Ivy Hill Asset Management, L.P. (IHAM).
Has ARCC Found The Bottom And Ready To Gain Momentum? Find Out Here
Orexigen Therapeutics, Inc. (NASDAQ:OREX) remained among the day decliners and traded with volume of 2.87 million shares in the last session, as compared to average volume of 858,068.00 shares. In comparison with 52 week range of $3.91- $7.84, it faced lowest price of $6.44 during the last trading session whereas its day highest price was $6.71. The company’s total market capitalization is $647.78 million, along with 98.97 million shares outstanding. Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its product candidates include Contrave, which has completed Phase III clinical trials and is being studied in a cardiovascular outcomes trial; and Empatic, which has completed Phase II clinical trials.
Why Should Investors Buy OREX After the Recent Fall? Just Go Here and Find Out
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) started its last trading session with the price of $10.77 and closed at $11.06 by scoring 2.55%. The stock traded with total volume of 3.00 million shares, while the average trading volume remained 1.20 million shares. The beta value of this stock stands at 0.52. Day range for the stock was $10.42 - $11.11. Neurocrine Biosciences, Inc. engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States.
Why Should Investors Buy NBIX After The Recent Gain? Just Go Here and Find Out
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)